vadimezan has been researched along with 5-hydroxytryptophan in 1 studies
Studies (vadimezan) | Trials (vadimezan) | Recent Studies (post-2010) (vadimezan) | Studies (5-hydroxytryptophan) | Trials (5-hydroxytryptophan) | Recent Studies (post-2010) (5-hydroxytryptophan) |
---|---|---|---|---|---|
272 | 16 | 101 | 4,177 | 157 | 298 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baguley, BC | 1 |
1 review(s) available for vadimezan and 5-hydroxytryptophan
Article | Year |
---|---|
Small-molecule cytokine inducers causing tumor necrosis.
Topics: 5-Hydroxytryptophan; Animals; Antineoplastic Agents; Capillary Permeability; Cytokines; Endothelium, Vascular; Flavonoids; Humans; Interferon-alpha; Mice; Microcirculation; Necrosis; Neoplasms; NF-kappa B; Nitric Oxide; Tumor Necrosis Factor-alpha; Xanthenes; Xanthones | 2001 |